Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Xcellbio announced today that it had granted bluebird bio, Inc., a commercial license and entered into a supply agreement for the use of Xcellbio’s proprietary cell manufacturing technology, AVATAR™, ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the ...

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...

The innovative system merges two previously separate streams of biological data: gene activity at the single-cell level and ...

Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...